Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CTMX

CytomX Therapeutics Inc

May 07 • 04:00PM ET

4.00

-0.13 -3.15 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR ZYME STRO JANX NRIX

| Held by: VTI XBI VXF IBB FDM VHT FFSM LABU DFAS CANC

Scroll to Statements

Index	-	P/E	439.56	EPS (ttm)	0.01	Insider Own	21.63%	Shs Outstand	170.19M	Perf Week	-5.21%
Market Cap	864.71M	Forward P/E	-	EPS next Y	-0.57	Insider Trans	-0.62%	Shs Float	169.43M	Perf Month	-5.88%
Enterprise Value	731.90M	PEG	-	EPS next Q	-0.10	Inst Own	61.07%	Short Float	16.24%	Perf Quarter	-23.66%
Income	-20.37M	P/S	11.35	EPS this Y	-238.61%	Inst Trans	5.00%	Short Ratio	4.08	Perf Half Y	-2.20%
Sales	76.20M	P/B	6.88	EPS next Y	-12.52%	ROA	-12.62%	Short Interest	27.52M	Perf YTD	-6.10%
Book/sh	0.58	P/C	6.31	EPS next 5Y	-	ROE	-35.25%	52W High	8.21 -51.28%	Perf Year	316.45%
Cash/sh	0.63	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-17.54%	52W Low	0.91 340.43%	Perf 3Y	135.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	98.19%	Volatility	5.50% 5.87%	Perf 5Y	-53.22%
Dividend TTM	-	EV/Sales	9.60	EPS Y/Y TTM	-97.67%	Oper. Margin	-29.48%	ATR (14)	0.29	Perf 10Y	-66.97%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	-44.82%	Profit Margin	-26.73%	RSI (14)	38.30	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	-173.57%	SMA20	-9.04%	Beta	2.16	Target Price	13.67
Payout	-	Debt/Eq	0.04	Sales Q/Q	-98.26%	SMA50	-13.39%	Rel Volume	0.45	Prev Close	4.13
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	3.25%	Avg Volume	6.75M	Price	4.00
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.42% 119.08%	Trades		Volume	3,097,434	Change	-3.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)